FDA Releases Pharmacogenomics Data Submission Guidance

The US Food and Drug Administration this week released its Pharmacogenomics Data Submissions guidance.

Released in draft form in November 2003, and then delayed numerous times before being released in its final form, the guidance may encourage drug makers to use pharmacogenomics technologies in their drug-discovery efforts. This in turn may spur greater investment in SNP-genotyping, gene expression, RNAi, and gene sequencing technologies and services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.